NCT05707923 How Simplified Language Affects Comprehension and Learning in Young Autistic Children
| NCT ID | NCT05707923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Michigan State University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 104 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 104 participants in total. It began in 2023-06-01 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young children with ASD (relative to full, grammatical utterances). The proposed project will investigate three specific aims: 1) Determine how single-word and telegraphic simplification affects language processing. 2) Determine how single-word and telegraphic simplification affects word learning. 3) Evaluate child characteristics that may moderate the effects of linguistic simplification on language processing and word learning. Aim 1 will test the hypothesis that children with ASD will process full, grammatical utterances faster and more accurately than single-word or telegraphic utterances. Aim 2 will test the hypothesis that full, grammatical utterances will support word learning better than telegraphic or single-word utterances. Aim 3 will test the hypothesis that language and cognitive skills significantly moderate the effects of linguistic simplification on language processing and word learning in young children with ASD.
Eligibility Criteria
Inclusion Criteria: * Existing or suspected autism spectrum disorder, confirmed through ADOS-2 * English as primary language * 1-4 years old Exclusion Criteria: * Known genetic condition (e.g., Down syndrome, fragile X) * Cerebral palsy * Acquired brain injury * Uncorrected vision or hearing impairment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05707923 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 4 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05707923 currently recruiting?
Yes, NCT05707923 is actively recruiting participants. Contact the research team at cvenker@msu.edu for enrollment information.
Where is the NCT05707923 trial being conducted?
This trial is being conducted at East Lansing, United States.
Who is sponsoring the NCT05707923 clinical trial?
NCT05707923 is sponsored by Michigan State University. The trial plans to enroll 104 participants.